Lisanti Capital Growth LLC acquired a new position in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 109,435 shares of the company’s stock, valued at approximately $8,638,000. TransMedics Group makes up 2.0% […]
TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) Director James R. Tobin sold 15,040 shares of the stock in a transaction on Wednesday, May 1st. The stock was sold at an average price of $106.43, for a total transaction of $1,600,707.20. Following the completion of the transaction, the director now directly owns 205,171 shares in […]
TransMedics Group (NASDAQ:TMDX – Free Report) had its target price increased by TD Cowen from $100.00 to $130.00 in a report published on Wednesday, Benzinga reports. TD Cowen currently has a buy rating on the stock. Other research analysts also recently issued reports about the stock. Morgan Stanley raised their price objective on shares of […]
TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) insider Tamer I. Khayal sold 63,260 shares of the stock in a transaction dated Wednesday, May 1st. The stock was sold at an average price of $108.54, for a total transaction of $6,866,240.40. Following the sale, the insider now directly owns 9,792 shares in the company, valued […]
TransMedics Group (NASDAQ:TMDX – Free Report) had its price target lifted by Canaccord Genuity Group from $102.00 to $117.00 in a research note published on Wednesday morning, Benzinga reports. The brokerage currently has a buy rating on the stock. Several other analysts also recently issued reports on the company. Morgan Stanley upped their price objective […]